New antibiotic could be effective against resistant bacteria
Published: Wednesday, Jan 3rd 2024, 17:20
Retour au fil d'actualité
A new class of antibiotics has shown promising results against an antibiotic-resistant bacterium in initial studies. However, the active ingredient developed by researchers at the pharmaceutical company Roche in Basel is still a long way from being used in practice.
According to the study published in the journal "Nature" on Wednesday, the newly developed active ingredient called zosurabalpine was effective in the laboratory and in mice against the antibiotic-resistant bacterium Acinetobacter baumannii - a typical hospital germ that can cause pneumonia, for example.
"Any new class of antibiotics that is able to treat infections caused by multidrug-resistant bacteria such as carbapenem-resistant Acinetobacter baumannii would be a major breakthrough," said Michael Lobritz from Roche, who was involved in the study, when asked by the Keystone-SDA news agency. However, further studies are needed to know whether zosurabalpine will bring about this breakthrough.
©Keystone/SDA
French 
English 
German 
Spanish 
Arabic